JRSM Short Reports · 2010 · 10 citations · 21 references
Life SciencesImmunologyNutritional SciencesInflammationMucosal ImmunologyNutritional ImmunologyEssential Fatty AcidsGastrointestinal InflammationGut-associated Lymphoid TissueInflammatory Bowel DiseaseInflammatory Bowel Disease CareMucosal InflammationClinical RemissionFatty AcidsInflammation Modulation By Fatty AcidsInflammatory Bowel Disease PathophysiologyInflammatory Bowel Disease TherapyOmega-3 Fatty Acid MetabolismOmega-3 Fatty AcidsUnsaturated Fatty Acids
Immunomodulation of the gut associated lynphoid tissue is a key issue in the clinical management of inflammatory bowel disease (IBD). Often toxic drugs are used to obtain clinical remission, sometimes in already immunocompromized patients. The presence of important co-morbidity might also heavily affect the clinical strategy. Polyunsaturated fatty acids (PUFAs) might represent a valid therapeutical option in IBD patients and further controlled clinical studies are warranted.
21
Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
R B Sartor · PubMed · 1997 · 396 citations
Life Sciences, Immunology, Pathology +17
SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITIS
J. H. Baron, Alastair M. Connell, J E Lennard-Jones et al. · The Lancet · 1962 · 293 citations